scispace - formally typeset
Open AccessJournal ArticleDOI

Significance of Circulating Tumor Cells Detected by the CellSearch System in Patients with Metastatic Breast Colorectal and Prostate Cancer.

M. Craig Miller, +2 more
- 01 Jan 2010 - 
- Vol. 2010, pp 617421-617421
Reads0
Chats0
TLDR
Comparing the outcomes from three prospective multicenter studies investigating the use of CTC to monitor patients undergoing treatment for metastatic breast, colorectal, or prostate cancer is compared and the CTC definition used in these studies is reviewed.
Abstract
The increasing number of treatment options for patients with metastatic carcinomas has created a concomitant need for new methods to monitor their use. Ideally, these modalities would be noninvasive, be independent of treatment, and provide quantitative real-time analysis of tumor activity in a variety of carcinomas. Assessment of circulating tumor cells (CTCs) shed into the blood during metastasis may satisfy this need. We developed the CellSearch System to enumerate CTC from 7.5 mL of venous blood. In this review we compare the outcomes from three prospective multicenter studies investigating the use of CTC to monitor patients undergoing treatment for metastatic breast (MBC), colorectal (MCRC), or prostate cancer (MPC) and review the CTC definition used in these studies. Evaluation of CTC at anytime during the course of disease allows assessment of patient prognosis and is predictive of overall survival.

read more

Citations
More filters
Journal ArticleDOI

Circulating Tumor Cells Correlate With Prognosis in Head and Neck Squamous Cell Carcinoma.

TL;DR: In this article, the relationship of circulating tumor cells (CTCs) and clinical characteristic parameters and prognosis in patients with head and neck squamous cell carcinoma (HNSCC) was investigated.
Journal ArticleDOI

Can molecular imaging enable personalized diagnostics? An example using magnetomotive photoacoustic imaging.

TL;DR: Results from phantom and in vitro studies demonstrate the capability of magnetomotive photoacoustic imaging to differentiate regions targeted with magnetic nanoparticles from the background, and to trap and sensitively detect targeted cells at a concentration of a single cell per milliliter in a flow system mimicking a human peripheral artery.
Book ChapterDOI

Circulating Tumor Cells in Gastrointestinal Cancer: Current Practices and Future Directions.

TL;DR: This chapter will review the current state of CTC research in GI cancers as well as the potential future applications that are currently being developed.

Comparing Sequential Steps For Detection Of Circulating Tumor Cells: More Specific Or Just Less Sensitive?

TL;DR: The approach without fixative detectsconsiderably more EpCAM-positive events with goodcell morphology as compared to the CellSave®fixation where cell morphology is poor, indicating more than 10-fold reduction inEpCAM accessibility by the preservative.
Journal ArticleDOI

Identification and characterization of transforming growth factor beta-induced in circulating tumor cell subline from pancreatic cancer cell line.

TL;DR: A highly malignant cell line derived from the human pancreatic cancer cell line Panc‐1 was established using an in vivo selection method and significantly expressed transforming growth factor beta‐induced (TGFBI), an extracellular matrix protein, more abundantly than did parent cells.
References
More filters
Journal ArticleDOI

The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited

TL;DR: It is now known that the potential of a tumour cell to metastasize depends on its interactions with the homeostatic factors that promote tumour-cell growth, survival, angiogenesis, invasion and metastasis.
Journal ArticleDOI

Isolation of rare circulating tumour cells in cancer patients by microchip technology.

TL;DR: The CTC-chip successfully identified CTCs in the peripheral blood of patients with metastatic lung, prostate, pancreatic, breast and colon cancer in 115 of 116 samples, with a range of 5–1,281CTCs per ml and approximately 50% purity.
Journal ArticleDOI

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases.

TL;DR: The CellSearch system can be standardized across multiple laboratories and may be used to determine the clinical utility of CTCs, which are extremely rare in healthy subjects and patients with nonmalignant diseases but present in various metastatic carcinomas with a wide range of frequencies.
Related Papers (5)